News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerus Corporation (CERS) Announces INTERCEPT Blood System for Platelets Regulatory Submission for Approval in South Africa


9/4/2012 10:16:45 AM

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that Ilex, Cerus’ exclusive distributor for South Africa, has submitted a regulatory dossier for approval of the INTERCEPT Blood System for platelets under a fast track designation by the South African Medicines Control Council (MCC).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES